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Abstract: The myoprotective effects of creatine monohydrate (CR) and whey protein (WP) are equivocal,
with the use of proxy measures of muscle damage making interpretation of their effectiveness limited.
The purpose of the study was to determine the effects of CR and WP supplementation on muscle
damage and recovery following controlled, chemically-induced muscle damage. Degeneration of the
extensor digitorum longus (EDL) muscle was induced by bupivacaine in rats supplemented with either
CR, WP, or standard rat chow (CON). At day 7 and 14 post-myotoxic injury, injured EDL muscles
were surgically removed and tested for isometric contractile properties, followed by the contralateral,
non-injured EDL muscle. At the completion of testing, muscles were snap-frozen in liquid nitrogen and
stored for later analysis. Data were analyzed using analysis of variance. Creatine-supplemented muscles
displayed a greater proportion of non-damaged (intact) fibers (p = 0.002) and larger cross-sectional areas
of regenerating and non-damaged fibers (p = 0.024) compared to CON muscles at day 7 post-injury.
At day 14 post-injury, CR-supplemented muscles generated higher absolute forces concomitant with
greater contractile protein levels compared to CON (p = 0.001, p = 0.008) and WP-supplemented muscles
(p = 0.003, p = 0.006). Creatine supplementation appears to offer an element of myoprotection which was
not observed following whey protein supplementation.
Keywords: dietary supplementation; injury; regeneration
1. Introduction
The etiology of the damage/repair process and alterations in muscle function following
unaccustomed, eccentric exercise has been extensively studied [1–4]. Disturbances in the regulation
and concentration of intracellular Ca2+ and changes in the rate of muscle protein degradation appear
to be an integral part of this process [5–7]. Enhancing muscle recovery could involve ameliorating
the initial insult of injury by improving the Ca2+ handling ability of the muscle and/or increasing
the rate of regeneration by augmenting muscle protein synthesis. While other contributing factors,
such as post-injury inflammation, and proliferation and differentiation rates of muscle satellite cells
and myoblasts, respectively, can modulate regenerative capacity, the ability of muscle to buffer the
initial physiological damage signal and induce regenerative activity remain fundamental in achieving
complete functional recovery [4].
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Dietary supplements creatine monohydrate (CR) and whey protein (WP) have previously
demonstrated ergogenic roles in exercise performance and recovery, and subsequent adaptations from
exercise training [8,9]. However, the effects of CR and WP supplementation on indicators of muscle
damage and recovery after injury in both human [10–25] and animal [26–28] models are equivocal. Studies
using acute ingestion of CR before (~20 g/day) and/or after exercise (~2–3 g/day) have reported no effect
on the extent of muscle damage and/or recovery following a high-force, eccentric exercise [12] or low force,
hypoxic resistance exercise challenge [11], respectively. Similarly, but utilizing a higher dosage of 40 g/day
before and 10 g/day after exercise, CR ingestion had no significant benefit on markers of muscle damage
and recovery following eccentric contractions of the elbow flexor muscles [13]. These observations have
also been supported following chemically-induced muscle damage, with CR supplementation ineffective
in accelerating the time course of muscle recovery in rodents [27]. In contrast, Bassit et al. [26] showed
that acute CR supplementation (5 g kg−1 body weight per day) for five days was able to attenuate muscle
strength loss and rise in plasma markers of muscle damage (i.e., lactate dehydrogenase (LDH) and creatine
kinase (CK)) following electrically-induced muscle damage in rats. Furthermore, the same authors reported
potential protective effects in triathletes following an ironman competition, albeit, with a low sample
size [26]. In support of these findings, Cooke et al. [10] reported higher isometric and isokinetic leg
extension strength and lower plasma CK levels when CR was supplemented before (~20 g/day) and
during the days after (~7 g/day) an intense resistance exercise session.
The majority of WP supplementation studies have focused on the purported benefits of higher protein
intake during periods following damaging exercise to enhance recovery [9]. White and colleagues [16]
found no significant improvement in the rate of muscle recovery following maximal isokinetic eccentric
contractions of the quadriceps when WP (23 g) was ingested pre- or post-exercise. Conversely, Buckley
et al. [23] showed improved muscle strength recovery when WP hydrolysate (25 g) was ingested during
the days following an intense exercise bout (i.e., 100 maximal knee extensions of the knee extensors)
compared to a placebo. However, given no significant elevation in an indirect marker of muscle damage
(i.e., CK) was observed, reduced fatigue, rather than attenuation of muscle damage most likely occurred.
Notwithstanding, consumption of WP isolate (~25–30 g, 4 times a day) during the days following an intense
resistance exercise session attenuated decrements in muscle strength and rises in LDH [25].
A limitation in human studies is the use of proxy measures of muscle damage/recovery. This can
introduce confusion regarding whether the benefits of supplementation are beyond the initial fatigue
recovery or the result inherent to damage. Moreover, the damage protocols typically used in
human studies (i.e., downhill running, isolated eccentric contractions) result in high variability in the
magnitude of muscle damage, and consequently the effects from the supplement intervention are
often variable. Thus, the use of animal models allows for a more direct and comprehensive analysis of
muscle damage and regeneration following injury. The purpose of this study was to examine temporal
changes in functional, morphological, and biochemical characteristics of muscle recovery following
a controlled, standardized, chemically-induced injury to identify potential myotherapeutic benefits of
CR and WP. We hypothesized that CR and WP supplementation would restore injury-induced loss
of isometric contractile strength sooner by either blunting the extent of the initial damage and/or
improving the rate of fiber regeneration.
2. Materials and Methods
2.1. Animals
Fifty-one male Sprague–Dawley rats (Rattus norvegicus) weighing 212.4 + 25.1 (mean ± standard
deviation (SD)) were randomly separated into three groups: (i) standard rat chow (CON) n = 18;
(ii) CR-supplemented n = 15; and (iii) WP-supplemented n = 18. Five animals (three CON and
two WP) were not used for subsequent contractile and/or biochemistry and histological analysis
due to the following reasons: animal died under anaesthesia (two animals); and isolated muscles
dissected could not be tested due to surgical procedure issues (three animals). Control rats were fed
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standard rat chow for a period of 14 days prior to, and 14 days following chemically-induced damage.
CR-supplemented rats were fed CR monohydrate (AST Sports Science, CO, USA) as a 0.02% (2 g
creatine/100 g standard rat chow) mixture for five days (loading phase), and a maintenance dosage of
0.002% (0.2 g creatine/100 g standard rat chow) mixture for nine days prior to chemically-induced
damage. Following injury, rats continued to consume the maintenance dosage (0.002%) for either 7
or 14 days. WP-supplemented rats were fed WP isolate (AST Sports Science, CO, USA) at 5 g kg−1
body weight per day in the chow for a period of 14 days following chemically-induced damage.
The CR and WP dosages used in the current study were converted from a human equivalent dose on
the basis of body surface area [29]. The human equivalent dose for CR was 0.3 g kg−1 body weight
per day for the loading phase and 0.03 g kg−1 body weight per day for the maintenance phase [8].
The human equivalent dose for WP was ~0.25 g kg−1 body weight every four hours over a 24 hour
period [30]. Since WP was provided in the chow and not given as a single bolus every four hours, we
administered ~60 g of WP per day based on rats consuming ~20 g every four hours over a 12-hour
period (dark cycle). For a 70 kg individual, this would equate to ~0.85 g kg−1 body weight per day,
or ~5.27 g kg−1 body weight per day for rats (rounded down to 5 g for ease of supplement mixing).
Animals were acquired from Monash Animal Services (Monash University, Melbourne, Australia)
and housed at the animal holding facility at Werribee campus, Victoria University. All procedures
described below received ethical approval from the Victoria University Animal Ethics Committee and
conformed to the “Principles of laboratory animal care” (NIH publication No. 86–23, revised 1985)
and the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Animals
were housed at a constant temperature (22 ◦C) under a 12:12-h light-dark photoperiod. Animals were
housed in pairs (body weight matched) prior to muscle injury in accordance with ethical approval.
While a more accurate measurement of the level of CR and WP supplementation would be obtained if
the rats were housed separately, there was no evidence to suggest that there was an uneven distribution
of supplementation between cage mates, since rats were fed ad libitum, and similar increases in body
mass were seen in both rats in each cage. All animals were housed separately following muscle injury
in accordance with ethical approval, with access to standard or supplemented chow ad libitum.
2.2. Experimental Procedures
All rats were lightly anesthetized with a Domitor (10 mg kg−1 body weight) and ketamine
(6 mg kg−1 body weight) combination via an intraperitoneal injection (i.p.), such that they were
unresponsive to tactile stimuli. The fur on the hindlimb was cut short, shaved, and cleaned using
standard aseptic techniques. The extensor digitorum longus (EDL) muscle was then surgically
exposed, with care taken to avoid damaging its nerve and blood supplies, and then injected
with 0.5% bupivacaine hydrochloride (bupivacaine) (Bupivacaine Hydrochloride, Pharmacia and
Upjoin (Perth) Pty. Ltd., Bentley, WA, Australia), through several injections in the distal, proximal,
and mid-belly regions of the muscle, using a 26-gauge needle. All muscles received the same amount
of bupivacaine (0.5 mL). This procedure causes degeneration of most fibers in the injected muscle [31].
The contralateral EDL muscle served as an uninjured control, and was not injected intramuscularly
as previous research has shown that little or no damage is caused by the insertion of the needle
itself, or the injection of an otherwise harmless vehicle such as isotonic saline [31]. Following injury,
the small incision was closed with Michel suture clips and swabbed with Betadine antiseptic (povidone
iodine solution). Anaesthesia was reversed using Antisedan®(Atipamezole Hydrochloride, Zoetis Inc.
Parsippany, NJ, USA) and animals continued their dietary modification.
2.3. Assessment of Contractile Properties
At 7 and 14 days post-injury, rats received intra-peritoneal injections of 60 mg kg−1 body weight
Nembutal. A longitudinal incision was made into the injured hind leg of the rat. Each muscle was
carefully dissected free from other tissues, starting from the proximal end, and placed into a horizontal,
custom-built plexiglass bath containing a Krebs–Henseleit Ringer solution (NaCl 118 mM; KCl 4.75 mM;
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Na2HPO4 1 mM; MgSO4·7H2O 1.18 mM; NaHCO3 24.8 mM; CaCl2 2.5 mM; and D-Glucose 11.0 mM).
The buffer solution was maintained at a pH of 7.4 and temperature of 25 ◦C. For all muscles, optimal
muscle length (Lo), force-frequency relationship, peak twitch force (Pt), and maximum isometric force
(Po) were determined according to previously published procedures from our lab [32]. Optimal fiber
length (Lf) was determined with the previously established Lf-to-Lo ratio of 0.44 for the EDL muscle [33].
Peak tetanic forces were expressed relative to the muscle’s cross-sectional area (specific force (sPo))
enabling comparisons between muscles of different area and length. Muscle cross-sectional area (CSA)
was calculated taking into account muscle mass, Lf, and 1.06 g/m3, the density of mammalian skeletal
muscle [34]. Immediately after the functional measurements, the muscle was removed from the bath,
blotted dry on filter paper, and weighed. The muscle was then divided into two sections; one-half was
coated with optimal cutting temperature (OCT) compound and snap-frozen in isopentane, cooled in
liquid nitrogen, and stored for subsequent histological analysis. The other portion was immediately
snap-frozen and stored for subsequent muscle protein analysis. The same procedure was then performed
on the contralateral, non-damaged EDL muscle. Following removal of all muscles required for analysis,
rats were killed by overdose of anaesthetic.
2.4. Histological Analysis
Histological procedures were performed to examine the effects of dietary supplementation on
general tissue morphology of both injured and uninjured muscles, following 7 and 14 days of treatment.
Using a cryostat microtome set at −20 ◦C (Microm GmbH D-6900; Heidelberg, West Germany),
transverse sections (10 µm thick) were cut from each muscle sample as close to the mid-belly as possible,
and placed onto a microscope slide. Sections were fixed in 10% buffered formol saline solution and
stained with routine haematoxylin and eosin, as previously described [35]. Digital images of muscle
sections were obtained using a camera (Zeiss Axiolab; Carl Zeiss GmbH, Jena, Germany) attached
to an upright Carl Zeiss light microscope (Zeiss Axiolab; Carl Zeiss GmbH, Jena, Germany) at 5×,
10×, and 20× magnification. Each section was examined in a single blinded manner, using calibrated
Analytical Imaging Station (AIS, v6.0 Imaging Research, Ontario, Canada) software. The mean cross
sectional (CSA) of individual fibers was calculated by interactive determination of the circumference
of at least 150 adjacent fibers from the center of each muscle section [36]. A quantitative estimate of the
relative affected area within cross sections of muscle samples was determined using a similar method
described elsewhere [37]. Each muscle section was categorized into three distinct regions: (1) muscle
damage (i.e., necrosis, inflammatory cell accumulation, and few small-multinucleated regenerating
fibers); (2) regenerating fibers (i.e., muscles showing larger regenerating fibers with centrally located
nuclei); and (3) normal fibers (i.e., muscles showing multi-nucleated intact fibers).
2.5. Protein Analysis
The muscle protein content was assessed in both injured and uninjured muscles, following 7
and 14 days of treatment, according to a modified version of methods described by Beitzel et al. [38].
Briefly, approximately 10–20 mg of the muscle were ground-glass homogenized on ice in 50 µL of
ice-cold, homogenizing buffer solution A (containing in mM: KCl 50, KH2PO4 10, MgCl2·6H2O 2,
EDTA 0.5, DTT 2) per mg of muscle (i.e., a 1:50 wet weight: volume dilution). Two hundred microliters
of crude homogenate were transferred into a labelled cryule and immediately snap-frozen and stored
in liquid nitrogen for later assessment of total protein concentration. The remainder of the homogenate
was centrifuged at 5 ◦C for 10 min at 1000 G. The supernatant, containing the cytosolic proteins,
was discarded and the pellet, containing the contractile proteins, was re-suspended in 200 µL of the
ice-cold, homogenizing buffer solution A. The suspension was transferred into a labelled cryule and
immediately snap-frozen and stored in liquid nitrogen for later assessment of contractile protein
concentration. Protein concentration was determined according to methods described by Bradford [39]
using a Bradford Protein Assay (Bio-Rad Protein assay, Bio-rad Laboratories, Hercules, CA, USA).
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2.6. Statistical Analysis
Data normality was assessed by Shapiro–Wilk test. All values are reported as means ±
standard deviation (SD). Statistical evaluation for each recovery time point (i.e., day 7 and day
14) was accomplished using a two-way analysis of variance (ANOVA) with supplement groups
(CR, WP, and CON), and experimental condition injured and uninjured (NORM) as factors. When
appropriate, differences between groups were tested with a Newman–Keuls post-hoc test, especially to
compare values measured during muscle regeneration with those observed in contralateral uninjured
muscle. Differences in animal morphology characteristics between groups were assessed by unpaired
(independent) students’t-test. Target and observed supplementation dosage within groups was
assessed by chi-square test. An alpha value 0.05 was considered statistically significant.
3. Results
3.1. Supplement Ingestion
Creatine-supplemented rats consumed 318 ± 18 mg per day for five days and 29 ± 3 mg per
day for nine days prior to myotoxic injury. These supplement intakes were lower than the expected
target dosage of 475 mg and 50 mg per day, respectively. Following myotoxic injury, CR-supplemented
rats consumed 28 ± 5 mg and 31 ± 0.5 mg per day, for 7 and 14 days, respectively. These observed
CR supplement intakes were also lower than the expected target dosage of 50 mg per day. Rats
supplemented with WP for 7 days and 14 days following myotoxic injury consumed 699 ± 10 mg and
724 ± 9 mg per day, respectively. Similar to the CR-supplemented rats, the WP intake was lower than
the expected target dosage of 1.25 g per day following myotoxic injury, and thus, the target dosages for
both supplements were not achieved post-injury/surgery.
3.2. Body Weight and Muscle Mass
Body weights for all groups are presented in Table 1. When expressed as a change from initial body
weight, CR-supplemented rats gained significantly more body mass (approximately 6 g) compared
to CON after 2-weeks supplementation (Group 1, p < 0.05). A similar trend was observed for
CR-supplemented rats in Group 2, although this was not deemed statistically significant (p = 0.094).
No significant changes were observed in the WP-supplemented animals when expressed relative to
initial body weight (Table 1).
Table 1. The effect of standard rat chow diet (CON), creatine (CR), and whey protein (WP) supplementation
on animal body weights (BW) (g).
Group 1 Initial BW (g) BW (g) after 14 Days BW (g) after 21 Days
CON (n = 9) 184.8 ± 23.6 209.4 ± 27.9 222.5 ± 24.2
CR (n = 7) 201.4 ± 16.4 232.3 ± 20.0 # 248 ± 18.5
Group 2 Initial BW (g) BW (g) after 14 days BW (g) after 28 days
CON (n = 9) 217.3 ± 15.7 243.7 ± 19.9 259.2 ± 21.4
CR (n = 8) 210.6 ± 14.8 242.0 ± 19.1 260.1 ± 19.5
Group 3 Initial BW (g) BW (g) after 7 days
WP (n = 9) 224.8 ± 24.8 234.4 ± 18.1
Group 4 Initial BW (g) BW (g) after 14 days
WP (n = 9) 232.9 ± 22.3 249.1 ± 28.6
Note: Values are presented as means ± SD. CR-supplemented groups were measured two weeks prior to injury
(initial Body weight (BW)), on the day of injury protocol (BW after 14 days), and on either day 7 post-injury (Group 1:
BW after 21 days) or day 14 post-injury (Group 2: BW after 28 days). Rat BW (g) for WP-supplemented groups were
measured at day 7 (Group 3) and 14 (Group 4) post-injury. Please note that for Group 3 and 4, initial body weight is
on the day of surgery; # (p < 0.05) significantly different from control muscles.
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The effects of bupivacaine-induced myotoxicity on contractile, histological, and protein properties
in muscle have been described extensively elsewhere [40,41]. Thus, only the effects of the
investigational supplements are described in this paper. However, where appropriate, statistical
differences between injured and contralateral muscles are reported in tables and figures. In addition,
CR-supplemented muscles and WP-supplemented muscles are further categorized as CR-INJ and
CR-NORM, and WP-INJ and WP-NORM for injured and uninjured muscles, respectively, while CON
muscles are categorized as CON-INJ and CON-NORM for injured and uninjured muscles, respectively.
Muscle mass changes in CON-, CR-, and WP-supplemented EDL muscles at day 7 and 14
post-injury are summarized in Table 2. No significant differences in muscle mass were evident between
groups at day 7 post-injury (p < 0.05). A significant group effect was observed at day 14 post-injury
(p = 0.011), with subsequent analysis indicating CR-supplemented muscles were significantly heavier
than WP–supplemented (p = 0.003) muscles in both injured and uninjured muscles, with only a trend
observed against CON (p = 0.089). No differences in muscle mass to body mass ratio (MM:BM)
were evident between all groups at day 7 post-injury. However, by day 14 post-injury, a significant
group effect was observed (p = 0.025), with subsequent analysis revealing greater MM:BM in the
CR-supplemented animals compared to CON (p = 0.044) and WP-supplemented (p = 0.010) animals.
No group by experiment interactions were observed for muscle mass or MM:BM (Table 2).
Table 2. Morphometric and contractile properties of uninjured and injured EDL muscles from rats
treated with standard rat chow- (CON), whey protein- (WP), or creatine- (CR) supplemented rat chow
at 7 and 14 days post-injury.
Treatment CON-INJ WP-INJ CR-INJ CON-NORM WP-NORM CR-NORM
Duration
7 days
n 8 8 7 8 8 7
MM (mg) 100.2 + 21.7 * 115.5 + 28.9 * 113.2 + 6.7 * 117.9 + 27.3 124.0 + 25.7 129.1 + 14.5
CSA (µm2) 740.9 ± 99 *** 948.2 ± 163 *** 1082.4 ± 80 ***# 2046.6 ±149 2087.9 ± 561 2353.8 ± 463 #
MM/BM (mg·g−1) 0.44 + 0.07 * 0.50 + 0.10 * 0.49 + 0.05 * 0.54 + 0.09 0.52 + 0.08 0.54 + 0.06
Lo (cm) 2.9 ± 0.2 3.0 ± 0.2 2.9 ± 0.1 2.9 ± 0.1 3.0 ± 0.1 2.9 ± 0.1
Pt (mN) 120.1 ± 46 *** 278.1 ± 190 *** 220.7 ± 100 *** 610.6 ± 263 582.6 ± 238 493.9 ± 158
TTP (ms) 51.4 ± 11.9 54.6 ± 10.7 45.5 ± 13.3 46.0 ± 6.3 46.3 ± 13.7 44.8 ± 10.0
1
2 RT (ms) 82.1 ± 19.9 ** 78.4 ± 25.9 ** 53.3 ± 11.8 **¥# 57.4 ± 8.8 56.6 ± 20.1 51.4 ± 13.1 ¥#
14 days
n 7 8 8 7 8 8
MM (mg) 139.2 + 21.7 124.6 + 25.7 150.6 + 12.0¥ 145.4 + 11.8 139.4 + 20.3 153.9 + 8.8¥
CSA (µm2) 1476.5 ± 311 *** 1648.8 ± 205 *** 1627.6 ± 261 *** 2287.1 ± 222 2433.9 ± 385 2497.7 ± 319
MM/BM (mg·g−1) 0.52 + 0.08 0.50 + 0.07 0.58 + 0.07¥# 0.56 + 0.04 0.56 + 0.07 0.60 + 0.04¥#
Lo (cm) 3.1 ± 0.1 3.1 ± 0.1 3.1 ± 0.1 3.2 ± 0.3 3.1 ± 0.1 3.1 ± 0.2
Pt (mN) 452.2 ± 57 *** 383.9 ± 133 *** 562.9 ± 69 ***¥ 713.2 ± 230 668.5 ± 168 795.6 ± 69 ¥
TTP (ms) 51.7 ± 15.5 * 47.1 ± 10.9 * 45.1 ± 7.9 * 46.0 ± 6.9 38.4 ± 9.1 38.6 ± 4.0
1
2 RT (ms) 102.9 ± 66.8 ** 68.5 ± 14.6 **# 59.2 ± 12.7 **# 56.7 ± 8.1 45.8 ± 9.6 # 46.5 ± 4.5 #
Note: n = number of animals in each group, MM muscle mass, CSA, cross-sectional area, MM:BM muscle mass to
body mass ratio, Lo optimal length, Pt peak twitch force, TTP time to peak tension, 12 RT half relaxation time. Values
are mean ± SD. * (p < 0.05), ** (p < 0.01), *** (p < 0.001) significantly different from contralateral values. # (p < 0.01)
significantly different from control muscles at day 7 and/or day 14 post-injury. ¥ (p < 0.01) significantly different
from WP-supplemented muscles at day 7 and/or day 14 post-injury.
3.3. Contractile Properties
Contractile properties of all muscles are summarized in Table 2. CR and WP supplementation
had no significant effect on optimal length (Lo) at day 7 (p = 0.361) and day 14 (p = 0.802) post-injury.
Conversely, a significant group effect was observed for half relaxation time ( 12 RT) at day 7 (p = 0.024),
with CR-supplemented muscles demonstrating significantly faster 12 RT compared to CON (p = 0.011)
and WP-supplemented muscles (p = 0.026) post-injury. This was also evident at day 14, with
significantly faster 12 RT in the CR-supplemented and WP-supplemented muscles compared to CON
(p = 0.011, p = 0.031, respectively). CR and WP supplementation had no significant effect on time to
peak tension (TTPT) at day 7 or day 14 (p < 0.05) post-injury. Similarly, there were no differences in
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peak twitch force (Pt) at day 7 post-injury (p < 0.05). Conversely at day 14 post-injury, a main group
effect was observed for Pt (p = 0.009), with significantly higher Pt observed in the CR-supplemented
compared to WP-supplemented muscles (p = 0.003). A strong trend towards significance was evident
when compared to CON muscles (p = 0.057). A significant main group effect was observed for absolute
force (Po) at day 14 (p = 0.001), but not day 7 post-injury (Figure 1). Subsequent analysis revealed that
CR-INJ and CR-NORM muscles generated significantly higher forces than CON-INJ and CON-NORM
(p = 0.001), and WP-INJ and WP-NORM muscles (p = 0.003, Figure 1). When Po was normalized for
muscle size, a main group effect trend for specific forces (sPo) was observed at day 14 post-injury
(p = 0.071, Figure 2), with no significant differences at day 7 post-injury (Figure 2).
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3.4. Total and Contractile Protein
Muscle protein content was measured to confirm whether alterations in muscle mass could be
observed at the ultra-structural level (Table 3). Following 7 days recovery, no significant differences
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between groups were observed for total protein and contractile protein levels (p > 0.05). By day
14 post-injury, no significant differences between groups for total protein were evident; however,
a significant main group effect was detected for contractile protein content (p = 0.008). Significantly
higher contractile protein content was noted between CR-INJ and CR-NORM compared to CON-INJ
and CON-NORM muscles, respectively (p = 0.008), and WP-INJ and WP-NORM muscles, respectively
(p = 0.006). No significant differences in total protein and contractile protein were noted between WP
and CON muscles. In addition, CR and WP supplementation had no significant effects on contractile
protein percentage at any time point relative to the CON.
Table 3. Muscle protein content of uninjured and injured EDL muscles from rats treated with standard
rat chow- (CON), whey protein- (WP), or creatine- (CR) supplemented rat chow for 7 and 14 days.
Treatment CON-INJ WP-INJ CR-INJ CON-NORM WP-NORM CR-NORM
Duration
7 days
n 8 8 7 8 8 7
protein (mg/g) 116.3 ± 33.8 * 137.5 ± 38.5 * 142.9 ± 47.1 * 170.0 ± 33.8 163.8 ± 70.3 161.4 ± 43.7
contractile protein (mg/g) 30.6 ± 10.3 ** 32.9 ± 10.7 ** 41.9 ± 13.6 ** 46.9 ± 17.2 43.8 ± 12.4 52.4 ± 8.6
% Contractile protein 28.3 ± 11.7 24.0 ± 4.5 30.7 ± 9.4 29.4 ± 12.9 32.5 ± 19.3 34.4 ± 10.2
14 days
n 7 8 8 7 8 8
protein (mg/g) 127.1 ± 40.3 * 127.5 ± 41.3 * 156.3 ± 29.7 * 167.1 ± 35.9 145.0 ± 36.7 170.0 ± 20.0
contractile protein (mg/g) 32.4 ± 13.0 38.1 ± 12.8 46.6 ± 15.3 #¥ 42.1 ± 11.4 36.3 ± 9.9 54.3 ± 14.1 #¥
% Contractile protein 25.3 ± 4.8 31.7 ± 10.7 29.3 ± 5.8 25.1 ± 5.9 25.9 ± 8.8 32.5 ± 9.7
Note: n = number of animals in each group. Values are mean ± SD. * (p < 0.05), ** (p < 0.01) significantly different
from contralateral values. ¥ (p < 0.05) significantly different from WP-supplemented muscles at day 7 and/or day
14 post-injury.
3.5. Histological Analysis
Cross-sectional area of both intact (non-damaged) and regenerating muscles was measured to
determine whether the observed increases in muscle strength were due to changes in fiber hypertrophy
(Table 2). At day 7 post-injury, a significant main group effect was observed (p = 0.032), with subsequent
analysis revealing that the CSA of the regenerating and intact fibers of the CR-supplemented muscles
was significantly larger than the CON muscles (p = 0.010). No effects of supplementation were
evident at day 14 post-injury. Quantitative analysis (See Figure 3) of three distinct regions (i.e., muscle
damage, regenerating fibers, and normal fibers) showed a greater percentage (~19%) of non-damaged
fibers at day 7 post-injury following CR supplementation compared to CON (p = 0.002, Figure 4).
By day 14, less damage was noted between CR-supplemented animals compared to CON (p = 0.024),
and WP-supplemented animals compared to CON (p = 0.039, Figure 5).
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Figure 5. Muscle fiber recovery (expressed as a % of muscle CSA) of injured EDL muscles from rats
treated with standard rat chow- (CON-), whey protein- (WP-), or creatine- (CR-) supplemented rat
chow at day 14 post-injury. Values are mean ± SD expressed as either % of undamaged (intact) fibers,
regenerating fibers, and damaged fibers. # (p < 0.01) significantly different from the injured CON values.
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4. Discussion
Creatine supplementation prior to and following a controlled myotoxic injury episode was more
effective at restoring functional strength compared to whey protein and placebo supplementation.
This enhanced functional capacity was associated with reduced damage following the initial insult,
greater CSA of regenerating fibers during the early stages of recovery, and higher levels of muscle
contractile protein content during the later stages of recovery. On the contrary, WP seemed to
have delayed effects on muscle recovery, both functionally and structurally, following myotoxic
injury. The findings from the present study provide important information on the morphological and
biochemical mechanisms by which CR and WP are influencing recovery and elucidate the mechanisms
for improvements observed in human studies using similar supplementation protocols.
Numerous studies have confirmed that supplementation with CR in conjunction with
programmed resistance training is effective for augmenting gains in body and fat-free mass,
and muscular strength in both men and women [42–45]. These benefits are possibly due to enhanced
training-induced increases in satellite cell number and myonuclei concentration within skeletal muscle
fibers [46]. Furthermore, CR supplementation alone may increase muscle mass, which is likely
a reflection of increased water retention, rather than effects on mixed muscle protein synthesis [47,48].
In the present study, animals consuming CR gained more body weight (approximately 6 g) than
animals consuming standard rat chow over a two-week loading period, with this trend continuing
during the 14 days post-surgery period, but to a lesser degree. By day 14 post-injury, both injured
and uninjured muscles of the CR-supplemented animals were heavier than WP and CON muscles.
The heavier injured muscles of the CR-supplemented animals could be due to faster recovery as
evidenced by larger CSA of the regenerating fibers and higher contractile protein levels. Indeed, cell
culture studies have shown accelerated differentiation of myoblasts into hypertrophic myotubes as
a result of creatine’s ability to offset the inhibition of myogenic differentiation typically caused by high
levels of oxidative stress following injury [49–51]. The uninjured muscles also displayed higher total
protein levels and greater fiber CSA, suggesting CR-induced anabolic growth driven by increased
cellular hydration status [52]. In contrast, WP-supplemented animals displayed similar weight gain
compared to the CON animals, and no significant changes in fiber CSA and protein levels.
A primary outcome of this study was to determine whether CR and WP supplementation could
enhance the functional recovery of the muscle following myotoxic injury. Absolute forces in the
injured muscles of the CR-supplemented animals were closer to full recovery (~76% of uninjured
values) compared to injured WP muscles (~71% of uninjured values) and CON muscles (~65% of
uninjured values) by day 14 post-injury. Furthermore, both injured and uninjured muscles following
CR supplementation generated significantly higher forces than WP- and CON-supplemented muscles.
However, when corrections were made for cross-sectional area, specific forces were not significantly
different between groups. It should be noted that specific force, an indicator of force output based on
a given muscle size, can be influenced during the early stages of muscle regeneration by inflammation
and muscle swelling, and thus, may explain the non-significant differences between groups.
Histological analysis revealed a significantly higher proportion of intact (non-damaged) fibers in
the regenerating CR muscles compared to CON muscles during the early stages post-injury. In addition,
CSA of the regenerating and intact fibers was significantly larger in the CR-supplemented muscles
compared to the CON muscles. These observations suggest that CR supplementation is reducing the
extent of damage and/or enhancing the growth of the regenerating fibers. Though no corresponding
functional enhancement was noted at this time point (i.e., day 7) for CR supplementation, it appears
that morphological improvements occurring at this early stage may underpin the benefits observed in
the later stages of recovery (i.e., higher absolute forces at day 14).
Originally considered solely as a sports supplement, creatine has shown over the past two
decades that its role goes beyond cellular bioenergetics, with pleiotropic effects that converge to
maintain cell homeostasis, protect membranes, and reduce oxidative stress and apoptosis [50,53,54].
The reduced magnitude of damage following the initial injury insult could be due to improved
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calcium (Ca2+) handling ability of the muscle, and thus, less activation of self-accelerating, degradative
pathways that lead to damage and degeneration [55]. CK isoforms, together with its substrates CR
and phosphocreatine (PCr), represent an intricate cellular energy buffering and transport system [56].
The sarcoendoplasmic reticulum (SR) Ca2+ transport ATPase (SERCA) pump derives its adenosine
triphosphate (ATP) preferentially from PCr via SR-bound CK. A high ATP/adenosine diphosphate
(ADP) ratio within the vicinity of the SERCA pump allows the pump to function optimally [57].
During times of severe stress such as post-injury, increased PCr stores following CR supplementation
may enhance the function of these pumps, and thus, the Ca2+ handling of the muscle. Furthermore,
the antioxidant properties of CR may reduce the reactive oxygen species (ROS)-induced inhibition of
SERCA pump function [58], as well as damage to RNA and inhibition of mitochondrial permeability
transition, an early event in apoptosis [59,60].
Although SERCA pump activity was not measured directly in the current study, increased Ca2+
uptake rate by SR vesicles from tibialis anterior muscle following CR supplementation has been shown
in a previous study [61]. In the present study, the rate of muscle relaxation, which is an indirect
measurement of Ca2+ handling ability of the muscle, was significantly increased in both the injured
and uninjured muscles at day 7 and 14 post-injury following CR supplementation. This indirect
measurement of Ca2+ handling ability of the muscle could indicate CR supplementation is enhancing
SERCA pump function. ROS levels were not measured in the current study, and therefore, we can only
speculate on the role of ROS in the current study findings.
An interesting observation was that CR intake prior to injury and post-injury were lower than
the expected target dosages. The conversion calculations to determine the target dosages for CR was
based on an average rat weight of ~250 g. For example, given that CR-supplemented rats consumed
on average 318 ± 18 mg during the loading phase, and weighed closer to ~200 g, their dosage per
kg.bw would be around 1.6 g kg−1 body weight per day. If we divide by the rat conversion factor
(6.2), we obtain a value of 0.256 g kg−1 body weight per day, which for a 70 kg individual would
equate to ~18 g of CR per day. This is very close to the recommended dosage of ~20 g per day for
loading. Despite the lower intakes, it was clear that the beneficial effects of CR supplementation
were still apparent in the present study. Lower than expected target dosages were also seen in the
WP-supplemented animals post-injury, with supplement intakes lower than the supplement target
dosage of 5 g kg−1 body weight per day at day 7 and 14 post-injury. Given similar calculations as
described above, our rats were consuming around ~33 g per day, which is lower than the targeted
~60 g per day, and could be contributing to the minimal benefits observed from WP.
A number of limitations exist in the current study. Firstly, intramuscular PCr and CR levels were
not measured. Both injured and uninjured EDL muscles were tested for contractile properties, lasting
approximately 40 minutes, before they were frozen. Thus, variation in PCr breakdown for each muscle
would make it difficult to determine the effectiveness of the loading phase. Notwithstanding, given the
changes observed in body weight, muscle mass, and force output, we can assume that levels within the
muscles increased by ~20%, as typically reported following a standard loading regimen [62]. Secondly,
myotoxic injury results in a greater magnitude of damage, specifically the extent of muscle necrosis,
compared to human models of injury. This should be carefully considered when making comparisons
between models. The processes of regeneration are very similar in all models, albeit the absolute values
reported on the extent and trajectories of the regenerative process, which may vary considerably [63].
Finally, rats in the current study consumed their recommended dosage of WP in chow over a period of
time rather than in one meal via oral gavage, as performed in other studies [64,65]. We chose this route
of administration to avoid additional stress on the injured animals. However, we acknowledge that
not delivering the WP in one meal/bolus, could be a limitation to our supplementation protocol.
5. Conclusions
In summary, reducing the magnitude of damage following the initial injury to the muscle led
to enhanced functional and morphological characteristics during the later stages of muscle recovery,
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following creatine supplementation. In contrast, whey protein supplementation demonstrated less
impact on the histological, functional, and morphological characteristics of muscle recovery following
injury. The observed myoprotective effect of CR supplementation could be due to improved calcium
handling ability of the muscle following the initial insult and during the early recovery period. To gain
a better understanding of the regenerative processes occurring post-injury and the mechanisms
behind the supplements, future work should explore markers of satellite cell activation (i.e., Pax7+)
and expression of embryonic and neonatal myosin heavy chains. Furthermore, in vitro experiments
with myogenic progenitor cells supplemented with CR and WP would also be insightful. Reducing
the extent of initial damage and enhancing muscle recovery will not only benefit athletes during
intense training phases, competition, and recovery from injury, but may also have important clinical
implications in various myopathies.
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